SEA VISIONSEA VISION
SEA VISION
  • Chi siamo
    • La nuova sede
    • ESG – Environment, Social, Governance
  • yudoo
  • Soluzioni
    • Serializzazione e T&T
    • Ispezione NIR
    • Ispezione blister – kit
    • Ispezione packaging – codici
    • Ispezione codici non serializzati – caratteri – packaging
    • Roll2Roll
    • Flat 120
    • Smart PCA40
  • Servizi
  • News, Stampa, Eventi
  • Lavora con noi
LinkedinYouTubeInstagramFacebookTwitter
 
  • Italiano
    • English (Inglese)
  • Chi siamo
    • La nuova sede
    • ESG – Environment, Social, Governance
  • yudoo
  • Soluzioni
    • Serializzazione e T&T
    • Ispezione NIR
    • Ispezione blister – kit
    • Ispezione packaging – codici
    • Ispezione codici non serializzati – caratteri – packaging
    • Roll2Roll
    • Flat 120
    • Smart PCA40
  • Servizi
  • News, Stampa, Eventi
  • Lavora con noi
16 giugno 2017Articoli redazionali
global serialization

By November 2017, pharmaceutical manufacturers in the U.S. will have to comply with the U.S. Drug Supply Chain Security Act (DSCSA). As the deadline for global serialization draws closer, it is apparent that some companies are under-prepared and are unlikely to achieve compliance in time.

The U.S. deadline will be closely followed by the introduction of the European Falsified Medicines Directive (FMD) in 2019. For companies that will be supplying drug products in Europe, there is still time to act to ensure a fully operational serialization solution is in place in sufficient time.

In a piece for Contract Pharma, Carlos Machado, serialization director at SEA Vision U.S., discusses some of the key learnings that companies should take from the U.S. as they prepare for the regulations in Europe and for global serialization. He also highlights Turkey as a best practice example of serialization in operation.

More than 40 countries across the world have guidelines for item-level pharmaceutical serialization and traceability. Some countries, including Turkey, already have regulations in place, while others including the EU and the U.S. are in the deployment stages. It is a complex environment to navigate with different requirements across geographies, but prioritizing serialization is business critical and preparing early is the key to success.

In the U.S., it is likely that only 70% of small contract manufacturing organizations (CMOs) and contract packaging organizations (CPOs) will be ready for the DSCSA requirements later this year. It is important that companies preparing for the FMD don’t make the same mistakes.

Carlos highlights some of the lessons that can be learned from companies who have faced challenges in implementing serialization in the U.S., including the importance of future-proofing your serialization set-up to save time and money in the long term.

You can read more about some of the lessons learned from global serialization here.

 

Share now!
LinkedInTwitterFacebook
Related Post
Serialization communication practices
Joined up thinking: serialization in practice
25 luglio 2017
How to overcome the operational challenges of serialization
4 luglio 2017
implementing pharmaceutical serialization
Implementing pharmaceutical serialization
9 febbraio 2017
Search by keyword
News categories
  • Articoli redazionali (4)
  • Company life (17)
  • Comunicati stampa (22)
  • Corporate (9)
  • Customer care (3)
  • Eventi e fiere (23)
  • Premi e certificazioni (9)
  • Prodotti (20)
  • Sponsorships (5)
Tweets by SEA_Vision
Browse the site
SEA VISION
SEA Vision s.r.l. - Via Treves 9 E 27100 Pavia (PV) Italia Tel: +39.0382.529576 - marketingdept@seavision.it P. IVA IT01638840189

Terms and Conditions - Cookie Policy - Privacy Policy

It’s time to achieve your production efficiency 4.0 goals!
post simple _linkedin

Access Now the Product Tour of yudoo, our 4.0 Pharma Software Suite 4.0, and discover how.

Utilizziamo i cookie per essere sicuri che tu possa avere la migliore esperienza sul nostro sito. Se continui ad utilizzare questo sito noi assumiamo che tu ne sia felice ed accetti la nostra privacy policy.OkLeggi di più